NeuroSense Therapeutics Receives Orphan Drug Designation for Amyotrophic Lateral Sclerosis (ALS) Drug
NeuroSense Therapeutics, a Biotech organization is promoting PrimeC, a combination medicine which aims to slow or halt ALS progression, published today the initiation of two…